← FDA DRUG APPROVALS

FDA ANDA · ANDA070076

METHYLDOPA

Sponsor: RISING

APPLICATION
ANDA070076
TYPE
ANDA
ORIGINAL APPROVAL
1985-04-18
LATEST ACTION
2004-10-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METHYLDOPAPrescription
METHYLDOPA 250MG · TABLET · ORAL
METHYLDOPAPrescription
METHYLDOPA 500MG · TABLET · ORAL

Approval history

2004-10-26Labeling · Supplement 34AP
2004-08-06Labeling · Supplement 31AP
1999-06-25Labeling · Supplement 29AP
1998-08-25Labeling · Supplement 26AP
1996-05-20Labeling · Supplement 22AP
1993-03-19Labeling · Supplement 19AP
1992-07-16Labeling · Supplement 15AP
1990-12-17Labeling · Supplement 13AP
1989-04-11Labeling · Supplement 6AP
1985-04-18OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →